A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)

NCT01793441 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

223

Enrollment

INDUSTRY

Sponsor class

Conditions

Autism Spectrum Disorder

Interventions

DRUG: Placebo
DRUG: RG7314

Sponsor

Hoffmann-La Roche